2005
DOI: 10.1210/jc.2004-1288
|View full text |Cite
|
Sign up to set email alerts
|

Adenoviral Gene Transfer Allows Smad-Responsive Gene Promoter Analyses and Delineation of Type I Receptor Usage of Transforming Growth Factor-β Family Ligands in Cultured Human Granulosa Luteal Cells

Abstract: In the human ovary, cell growth and differentiation are regulated by members of the TGF-beta superfamily, including growth differentiation factor-9 (GDF9), TGF-beta, and activin. TGF-beta and activin are known to signal via Smad3 activation, and we have recently shown the involvement of Smad3 in cellular responses to GDF9. Recent studies with Smad3-deficient mice have also indicated a key role for this signaling mediator in ovarian folliculogenesis. We now demonstrate the use of a Smad3 reporter (CAGA-lucifera… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
34
0

Year Published

2007
2007
2019
2019

Publication Types

Select...
4
2
1

Relationship

1
6

Authors

Journals

citations
Cited by 47 publications
(38 citation statements)
references
References 42 publications
4
34
0
Order By: Relevance
“…This suggests that GDF9 is acting like a BMP rather than a TGFb, as TGFb1 had no significant effect on FSH secretion in either BB or WT genotypes. GDF9 is expressed in sheep pituitary tissue (Faure et al 2005) and the present theory is that GDF9 acts through the BMPRII receptor and TGFb type I receptors (Alk5) to activate the Smad 3 pathway (Kaivo-Oja et al 2005). BMP2 and BMP4 both bind to BMPRII and ALK3/6 (BMPRIA/B) activating the Smad 1/5/8 pathway, but BMP6 and BMP7 are thought to bind to BMPRII as well as the activin receptors ActRII/IIB and ALK2 (ActRIA) in addition to ALK6 (see Shimasaki et al 2004 for a review).…”
Section: Discussionmentioning
confidence: 99%
“…This suggests that GDF9 is acting like a BMP rather than a TGFb, as TGFb1 had no significant effect on FSH secretion in either BB or WT genotypes. GDF9 is expressed in sheep pituitary tissue (Faure et al 2005) and the present theory is that GDF9 acts through the BMPRII receptor and TGFb type I receptors (Alk5) to activate the Smad 3 pathway (Kaivo-Oja et al 2005). BMP2 and BMP4 both bind to BMPRII and ALK3/6 (BMPRIA/B) activating the Smad 1/5/8 pathway, but BMP6 and BMP7 are thought to bind to BMPRII as well as the activin receptors ActRII/IIB and ALK2 (ActRIA) in addition to ALK6 (see Shimasaki et al 2004 for a review).…”
Section: Discussionmentioning
confidence: 99%
“…In these initial studies, Smad3 activation was monitored by transducing human granulosa-luteal (hGL) cells with an adenovirus encoding the CAGAluciferase reporter (Kaivo-Oja et al 2005), which contains repeats of the Smad3/4 response element (GTCT/AGAC) in front of the luciferase cDNA (Dennler et al 1998). This lack of bioactivity in the case of hGDF9 was not due to a problem in the production of the protein or in processing of the precursor (Fig 1C).…”
Section: Page 6 Of 26mentioning
confidence: 99%
“…Bioactivity of the conditioned media and the purified GDF9 mature regions was assayed on primary cultures of hGL cells (Kaivo-Oja et al 2005). The hGL cells were treated with either purified mouse (Fig.…”
Section: C-terminally Tagged Mouse and Human Gdf9 Are Inactivementioning
confidence: 99%
See 1 more Smart Citation
“…Whether GDF9 acts directly on the oocyte to induce follicle growth, indirectly through the granulosa cell or both, is not clear, given that both granulosa cells and oocytes in primary follicles express ALK5 [57][58][59][60][61] and BMPR2 [58,62], the reported type I [63,64] and II receptors for GDF9 [65], respectively. However, it is controversial whether ALK5 is the only type I receptor for GDF9 as Alk5 conditional knockout mice have no defects in follicular development and cumulus expansion [62], which is a distinct phenotype from Gdf9 null mice [17].…”
Section: Discussionmentioning
confidence: 99%